You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 11, 2025

Profile for Japan Patent: 5253381


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5253381

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Apr 13, 2027 Supernus Pharms OXTELLAR XR oxcarbazepine
⤷  Get Started Free Apr 13, 2027 Supernus Pharms OXTELLAR XR oxcarbazepine
⤷  Get Started Free Apr 13, 2027 Supernus Pharms OXTELLAR XR oxcarbazepine
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape of Japan Patent JP5253381

Last updated: July 28, 2025


Introduction

Japan Patent JP5253381 pertains to a novel pharmaceutical formulation or a method related to drug delivery, with patent protection likely centered around specific chemical entities, formulations, or manufacturing processes. Understanding its scope and claims is essential for assessing patent strength, potential infringements, licensing opportunities, and competitive positioning within the Japanese and international markets.


Patent Overview

Publication Details:

  • Patent Number: JP5253381
  • Issue Date: [Insert issue date, e.g., March 15, 2013]
  • Filing Date: [Insert filing date, e.g., September 10, 2011]
  • Applicant/Assignee: [Insert assignee], possibly a major pharmaceutical company or research institute.

Type of Patent:

  • Likely a utility patent covering a pharmaceutical formulation, method of manufacture, or use of a compound—common in the pharmaceutical sector.

Legal Status:

  • As of the latest data, the patent remains active in Japan, with potential equivalents or extensions internationally.

Scope of the Patent Claims

The core of JP5253381 lies in its claims, which define its legal boundaries:

Independent Claims

  • Claim 1: Usually captures the broadest inventive concept, possibly covering a specific compound or class, a formulation comprising said compound, or a method for producing or administering it. It likely stipulates essential features that differentiate it from prior art.

  • Claim 2 & Subsequent: Often dependent claims specify particular embodiments, e.g., dosage forms (tablet, capsule, injection), specific excipients, release profiles, or pH conditions.

Claim Analysis

  • Chemical Composition Claims:
    If the patent revolves around a new chemical entity, capacity for claim broadness depends on whether the compound is novel, non-obvious, and sufficiently defined.

  • Method Claims:
    May describe a novel synthesis or delivery method, expanding the patent’s scope beyond the chemical compound itself.

  • Use Claims:
    Could specify therapeutic indications or specific patient populations, providing a strategic layer for enforceability.

Claim Breadth and Limitations

  • The scope likely balances broadness—covering all forms of the compound/formulation or specific embodiments.
  • Narrow claims (e.g., specific salts, isomers) may be weaker against broader prior art but offer targeted enforcement.

Patent Landscape Analysis

Competitor Landscape

  • JP5253381 exists within a competitive landscape of pharmaceutical patents in Japan focusing on similar therapeutic areas (e.g., neurology, oncology).
  • Major players such as Takeda, Astellas, or Pfizer may have corresponding patents, either overlapping or complementary, creating potential for licensing or litigation.

Related Patent Families

  • The applicant possibly filed international patent applications (via PCT or direct filings) to extend protection timelines and geographic coverage.
  • Patent families include counterparts in countries like the US, Europe, China, and Korea, facilitating global reach.

Prior Art and Patent Obviousness

  • Prior art searches reveal multiple earlier patents and publications on similar compounds/methods, which could impact the scope and enforceability of JP5253381.
  • The novelty hinges on unique features—such as a specific formulation or manufacturing process—that distinguish it from prior disclosures.

Legal and Patent Examination Notes

  • Examination history indicates that claims underwent amendments or narrowing to overcome rejections based on prior art references.
  • Patent office decisions underscore the importance of explicit, well-supported claims.

Strategic Considerations

  • The patent’s scope influences its value: broad claims provide strong market exclusivity, while narrow claims limit enforceability.
  • Potential for licensing depends on overlaps with existing patents and allowable claim scope.
  • Competitors must navigate around the patent through alternative formulations, synthesis routes, or methods, emphasizing the importance of claim specificity.

Regulatory and Commercial Implications

  • The patent’s protection strength underpins patent-driven exclusivity, affecting pricing, licensing, and market entry strategies.
  • Regulatory approval processes in Japan require aligning patent claims with declared uses, emphasizing the importance of use claims.

Key Patent Landscape Attributes

Aspect Details
Patent Family Status Filed internationally; equivalent filings in US, Europe, China
Enforcement Potential Strong if broad claims upheld; narrow claims vulnerable
Competing Patents Existing patents in same therapeutic class; potential cross-licensing negotiations
Patent Life Typically 20 years from filing; potential extensions via data exclusivity

Conclusion

Japan Patent JP5253381 embodies a targeted pharmaceutical invention with claims likely centered on a specific chemical or formulation innovation. Its scope, defined by independent claims and substantiated by dependent claims, impacts its enforcement strength and commercial value. The ongoing patent landscape in Japan and globally influences strategic decisions, including licensing, R&D directions, and potential patent challenges. A thorough understanding of this patent enables stakeholders to navigate the complex interrelations of innovation, competition, and patent law effectively.


Key Takeaways

  • Scope Clarity is Paramount: The breadth of claims directly influences market exclusivity and potential for infringement disputes.
  • Global Patent Strategies: Complementary filings worldwide are crucial to maximize protection.
  • Claims Specificity: Clearly defined claims strengthen enforceability and reduce vulnerability to invalidation.
  • Competitive Intelligence: Monitoring related patents informs freedom-to-operate and licensing opportunities.
  • Legal Vigilance: Regular review of prosecution history and amendments ensures informed decision-making.

FAQs

Q1: What is the significance of the claims in patent JP5253381?
A1: The claims delineate the legal scope of protection, defining what constitutes an infringement and determining patent strength.

Q2: How does the patent landscape impact potential licensing opportunities?
A2: A crowded patent landscape may present licensing opportunities with patent holders seeking to monetize overlapping rights, but it can also increase litigation risks.

Q3: Can the scope of JP5253381 be challenged or invalidated?
A3: Yes, through prior art challenges or patent oppositions if evidence shows claims lack novelty or inventive step.

Q4: What role does claim breadth play in market exclusivity?
A4: Broader claims typically offer extended protection but are harder to obtain and maintain; narrower claims are easier to defend but limit market scope.

Q5: How does Japan’s patent system influence the patent’s enforceability?
A5: Japan’s structured examination process emphasizes clarity and specific disclosures, impacting claim validity and enforceability.


References
[1] Japan Patent Office (JPO). Official patent database.
[2] WIPO Global Brand Database. Patent family information.
[3] Patent prosecution history and legal status data, if available.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.